Skip to main content
Pablo Pergola, MD, Nephrology, San Antonio, TX, Baptist Medical Center

PabloEzequielPergolaMDPhD

Nephrology San Antonio, TX

Renal Associates PA

Dr. Pergola is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Pergola's full profile

Already have an account?

Education & Training

  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Nephrology, 1997 - 1999
  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1994 - 1997
  • Univ Salvador- Fac Med
    Univ Salvador- Fac MedClass of 1988

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1998 - 2024
  • American Board of Internal Medicine Nephrology
  • National Board of Physicians and Surgeons Internal Medicine
  • National Board of Physicians and Surgeons Nephrology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • NRF2 Pathway: Why Is It Important in Kidney Diseases? 
    American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/9/2019

Press Mentions

  • Reata Pharma Shares Trading Higher After Reacquiring U.S. And Worldwide Licensing Rights
    Reata Pharma Shares Trading Higher After Reacquiring U.S. And Worldwide Licensing RightsOctober 14th, 2019
  • Reata Announces Presentations at the 56thCongress of the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA)
    Reata Announces Presentations at the 56thCongress of the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA)June 4th, 2019
  • Effect of Bardoxolone Methyl on the Urine Albumin-to-Creatinine Ratio in Patients with Type 2 Diabetes and Stage 4 Chronic Kidney Disease
    Effect of Bardoxolone Methyl on the Urine Albumin-to-Creatinine Ratio in Patients with Type 2 Diabetes and Stage 4 Chronic Kidney DiseaseMay 16th, 2019
  • Join now to see all

Other Languages

  • Spanish

Hospital Affiliations